End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,560 KRW | -1.35% | +10.82% | -36.95% |
Apr. 25 | Noul Announces 2 Clinical Performance Studies At Pan-African Malaria Conference | CI |
2023 | Noul Co., Ltd. Unveils the Result of Malaria Study in Ethiopia and Ghana | CI |
Sales 2022 | 542M 395K | Sales 2023 | 2.73B 1.99M | Capitalization | 150B 109M |
---|---|---|---|---|---|
Net income 2022 | -13.68B -9.97M | Net income 2023 | -16.32B -11.9M | EV / Sales 2022 | 182 x |
Net Debt 2022 | 140M 102K | Net cash position 2023 | 11.81B 8.61M | EV / Sales 2023 | 50.5 x |
P/E ratio 2022 |
-6.92
x | P/E ratio 2023 |
-6.67
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 69.57% |
1 day | -1.35% | ||
1 week | +10.82% | ||
Current month | +10.82% | ||
1 month | +2.61% | ||
3 months | -22.07% | ||
6 months | -51.97% | ||
Current year | -36.95% |
Managers | Title | Age | Since |
---|---|---|---|
Chan-Young Im
CEO | Chief Executive Officer | 45 | 15-11-30 |
Ri-Hyeon Kim
DFI | Director of Finance/CFO | 42 | 20-04-30 |
Dong-Young Lee
CTO | Chief Tech/Sci/R&D Officer | 45 | 15-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chan-Young Im
CEO | Chief Executive Officer | 45 | 15-11-30 |
Dong-Young Lee
CTO | Chief Tech/Sci/R&D Officer | 45 | 15-11-30 |
Kyung-Hwan Kim
BRD | Director/Board Member | 45 | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 2,560 | -1.35% | 361,329 |
24-05-07 | 2,595 | +8.58% | 1,281,834 |
24-05-03 | 2,390 | 0.00% | 276,184 |
24-05-02 | 2,390 | +3.46% | 649,530 |
24-04-30 | 2,310 | +0.87% | 412,412 |
End-of-day quote Korea S.E., May 07, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-36.95% | 69.3M | |
-19.60% | 10.94B | |
+64.70% | 3.75B | |
-31.09% | 2.27B | |
-10.77% | 2.25B | |
-26.86% | 1.54B | |
+35.42% | 1.18B | |
-2.40% | 754M | |
-35.10% | 469M | |
+14.91% | 340M |
- Stock Market
- Equities
- A376930 Stock